six-minute walk test

six-minute walk test

a pulmonary function test in which the distance a patient can walk over a 6-minute period is measured, usually including pulse oximetry. Used for prognosis, diagnosis, and response to therapy.

six-minute walk test

an assessment of a dog's ability to undertake daily activities.
References in periodicals archive ?
Patients treated with ATB200/AT2221 for up to 12 months showed improvements in six-minute walk test distance and other measures of motor function, stability or increases in forced vital capacity, and durable reductions in biomarkers of muscle damage and disease substrate.
Efficacy was primarily assessed via the six-minute walk test in ten patients who could perform the test.
The six-minute walk test, the modified Medical Research Council Dyspnea Scale, body plethysmographs, carbon monoxide diffusion tests, and arterial blood gas analysis were practiced.
Significant benefits were observed for gait outcomes of speed, the two- and six-minute walk test, functional and mobility outcomes of the Timed Up & Go test (how long it takes a person to get up from a chair, walk a certain distance, then walk back to the chair and sit down) and Functional Reach tests (how far a person can reach before he/she loses balance) and the Berg Balance Scale, which assesses multiple aspects of balance via a questionnaire.
Lung function and six-minute walk test performance in individuals with sickle cell disease.
By the end of 12 weeks, the patients showed improvements in distance walked on a six-minute walk test as well as quality of life improvements measured by the St George's Respiratory Questionnaire (SGRQ).
The six-minute walk test was possible after giving the patient the first series of G-CSF.
Age and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds.
17, 2016--Results from a study sponsored by CardioCell LLC show statistically significant improvement in six-minute walk test, quality-of-life scores as assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ) and favorable immune modulatory benefits after injections of mesenchymal stem cells.
17, 2016 --Results from a study sponsored by CardioCell LLC show statistically significant improvement in six-minute walk test, quality-of-life scores as assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ) and favorable immune modulatory benefits after injections of mesenchymal stem cells.